Skip to main content
Year archive

KYONGBO PHARMACEUTICAL CO., LTD. — 2020 filings

All 16 regulatory filings released by KYONGBO PHARMACEUTICAL CO., LTD. (214390) in 2020, sourced directly from the official regulator.

16 Filings
2020 Period
2020 filings (16)
Filing Released Lang
분기보고서 (2020.09)
Interim / Quarterly Report 9M 2020
2020-11-16 Korean
영업(잠정)실적(공정공시)
Earnings Release Q3 2020
2020-10-30 Korean
투자판단관련주요경영사항(특허권 취득)
Regulatory Filings
2020-08-18 Korean
반기보고서 (2020.06)
Interim / Quarterly Report H1 2020
2020-08-14 Korean
영업(잠정)실적(공정공시)
Earnings Release Q2 2020
2020-07-31 Korean
분기보고서 (2020.03)
Interim / Quarterly Report Q1 2020
2020-05-15 Korean
영업(잠정)실적(공정공시)
Earnings Release Q1 2020
2020-04-29 Korean
사업보고서 (2019.12)
Audit Report / Information FY 2019
2020-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2020-03-20 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-03-18 Korean
감사보고서제출
Audit Report / Information FY 2019
2020-03-12 Korean
주주총회소집공고
AGM Information
2020-02-28 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount
2020-02-26 Korean
주주총회소집결의
AGM Information
2020-02-26 Korean
주주총회집중일개최사유신고
AGM Information
2020-02-26 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Management Reports
2020-02-05 Korean